Cell Cycle Regulation, Checkpoints & Cancer
Learn how cyclins, Cdks and the G1, G2 and M checkpoints control cell division, and how mutated proto-oncogenes and tumor suppressor genes cause cancer.
What you'll do in this lesson
A voice-first session with the Crimsora tutor on Cell Cycle Regulation, Checkpoints & Cancer, then targeted practice and FRQs — with the tutor adapting to where you get stuck.
What this lesson covers
You already know the cell cycle as a sequence: interphase, mitosis, cytokinesis. But a sequence alone doesn't explain why a skin cell divides to heal a cut and then stops, while a cancer cell divides until it forms a tumor. The difference is regulation — a molecular control system that asks, at specific moments, "Should I keep going?"
This lesson opens up that control system. You will learn what the three major checkpoints actually check, how cyclin proteins and their partner enzymes act like a timer that pushes the cell forward, and how two opposing categories of genes — proto-oncogenes that say "go" and tumor suppressor genes that say "stop" — keep division balanced. Then you'll see what happens when those genes mutate. Cancer is not one broken part; it is an accumulation of several independent failures in the same cell lineage, which is why it usually takes years to develop.
This lesson opens up that control system. You will learn what the three major checkpoints actually check, how cyclin proteins and their partner enzymes act like a timer that pushes the cell forward, and how two opposing categories of genes — proto-oncogenes that say "go" and tumor suppressor genes that say "stop" — keep division balanced. Then you'll see what happens when those genes mutate. Cancer is not one broken part; it is an accumulation of several independent failures in the same cell lineage, which is why it usually takes years to develop.
Cyclins and Cdks: The Cell's Internal Timer
The cell cycle is driven forward by protein complexes made of two pieces. Cyclins are regulatory proteins whose concentration rises and falls in a predictable cycle — they are synthesized, they accumulate, and then they are destroyed. Cyclin-dependent kinases (Cdks) are enzymes that are always present but inactive on their own. A Cdk only becomes active when a cyclin binds to it.
Once active, the cyclin-Cdk complex works as a kinase: it attaches phosphate groups to specific target proteins, switching them on or off. Those targets are the proteins that actually do the work of the next phase — assembling replication machinery, condensing chromosomes, breaking down the nuclear envelope.
The key insight is that cyclin levels, not Cdk levels, set the timing. G1 cyclins accumulate during G1; when they reach a threshold, the G1/S transition occurs and DNA replication begins. M-cyclin (mitotic cyclin) accumulates through S and G2; when enough builds up, the cell enters mitosis. As soon as the cell passes into anaphase, mitotic cyclin is rapidly degraded, Cdk activity collapses, and the cell exits mitosis. The destruction of cyclin is just as important as its production — without it, the cell could not reset for the next cycle.
A common misconception is that cyclins "cut" or "cause" division directly. They don't. They are signals that activate enzymes, and those enzymes phosphorylate other proteins. Another frequent error is thinking Cdk concentration oscillates. Cdk stays roughly constant; its activity oscillates because its cyclin partner comes and goes.
Cyclin-Cdk complexes are also the machinery that checkpoints act on. A checkpoint that halts the cycle does so, ultimately, by blocking or inactivating a cyclin-Cdk complex.
Once active, the cyclin-Cdk complex works as a kinase: it attaches phosphate groups to specific target proteins, switching them on or off. Those targets are the proteins that actually do the work of the next phase — assembling replication machinery, condensing chromosomes, breaking down the nuclear envelope.
The key insight is that cyclin levels, not Cdk levels, set the timing. G1 cyclins accumulate during G1; when they reach a threshold, the G1/S transition occurs and DNA replication begins. M-cyclin (mitotic cyclin) accumulates through S and G2; when enough builds up, the cell enters mitosis. As soon as the cell passes into anaphase, mitotic cyclin is rapidly degraded, Cdk activity collapses, and the cell exits mitosis. The destruction of cyclin is just as important as its production — without it, the cell could not reset for the next cycle.
A common misconception is that cyclins "cut" or "cause" division directly. They don't. They are signals that activate enzymes, and those enzymes phosphorylate other proteins. Another frequent error is thinking Cdk concentration oscillates. Cdk stays roughly constant; its activity oscillates because its cyclin partner comes and goes.
Cyclin-Cdk complexes are also the machinery that checkpoints act on. A checkpoint that halts the cycle does so, ultimately, by blocking or inactivating a cyclin-Cdk complex.
The Three Major Checkpoints and What Each One Verifies
A checkpoint is a control point where internal and external conditions are evaluated before the cell commits to the next stage. If conditions fail, the cycle pauses — and if the damage cannot be repaired, the cell may undergo apoptosis, programmed cell death.
The G1 checkpoint is the most important decision point because it is where the cell commits. Before it, the cell can still back out and enter G0, a quiescent state where mature neurons and most muscle cells permanently reside. After it, the cell is generally committed to completing the cycle.
External signals matter here. Growth factors are proteins released by other cells that bind surface receptors and trigger a signal cascade ending in cyclin production. Normal cells also show density-dependent inhibition: when neighbors crowd them, they stop dividing. And most require anchorage to a surface. Cancer cells lose all three requirements, which is why they pile into layers in a culture dish while normal cells form a single sheet and stop.
Students often assume a checkpoint is a physical structure. It is better described as a molecular decision — a set of proteins that detect a problem and, in response, shut down the cyclin-Cdk complex that would otherwise push the cycle forward.
| Checkpoint | Location | What it verifies | Consequence of failure |
|---|---|---|---|
| G1 checkpoint (restriction point) | End of G1, before S | Cell size, nutrients, growth factor signals, DNA damage | Damaged or under-resourced DNA gets replicated instead of the cell arresting |
| G2 checkpoint | End of G2, before mitosis | DNA fully replicated once, no unrepaired breaks | Cell enters mitosis with broken or incomplete DNA |
| M checkpoint (spindle assembly checkpoint) | Metaphase, before anaphase | Every chromosome attached to spindle fibers from both poles | Sister chromatids separate unevenly, producing aneuploid cells |
External signals matter here. Growth factors are proteins released by other cells that bind surface receptors and trigger a signal cascade ending in cyclin production. Normal cells also show density-dependent inhibition: when neighbors crowd them, they stop dividing. And most require anchorage to a surface. Cancer cells lose all three requirements, which is why they pile into layers in a culture dish while normal cells form a single sheet and stop.
Students often assume a checkpoint is a physical structure. It is better described as a molecular decision — a set of proteins that detect a problem and, in response, shut down the cyclin-Cdk complex that would otherwise push the cycle forward.
Proto-oncogenes and Tumor Suppressor Genes: Gas Pedal and Brakes
Two gene categories with opposite jobs regulate division, and they fail in opposite ways.
Proto-oncogenes are normal, useful genes that code for proteins promoting cell division — growth factors, their receptors, and signaling proteins such as Ras. They are the gas pedal. A mutation that makes a proto-oncogene overactive or overexpressed converts it into an oncogene. This is a gain-of-function mutation: the protein now signals "divide" even when no growth factor is present. Because a single overactive copy is enough to send the signal, oncogene mutations are typically dominant at the cellular level.
Tumor suppressor genes code for proteins that inhibit division or trigger repair and apoptosis. They are the brakes. The classic example is p53, sometimes called the guardian of the genome: when DNA damage is detected, p53 levels rise, halting the cycle at G1 so repair enzymes can work, and triggering apoptosis if the damage is too severe. Rb blocks the G1/S transition until growth signals release it. Tumor suppressor mutations are loss-of-function, and because a cell usually has two copies, both alleles must generally be knocked out before the brake is truly gone — this is the two-hit idea, and it explains why inherited mutations in genes like BRCA1 raise risk without guaranteeing cancer: the person is born already one hit down in every cell.
A very common wrong answer treats oncogenes as foreign invaders. They are not — every one of your cells carries proto-oncogenes, and they are essential for wound healing and development.
Proto-oncogenes are normal, useful genes that code for proteins promoting cell division — growth factors, their receptors, and signaling proteins such as Ras. They are the gas pedal. A mutation that makes a proto-oncogene overactive or overexpressed converts it into an oncogene. This is a gain-of-function mutation: the protein now signals "divide" even when no growth factor is present. Because a single overactive copy is enough to send the signal, oncogene mutations are typically dominant at the cellular level.
Tumor suppressor genes code for proteins that inhibit division or trigger repair and apoptosis. They are the brakes. The classic example is p53, sometimes called the guardian of the genome: when DNA damage is detected, p53 levels rise, halting the cycle at G1 so repair enzymes can work, and triggering apoptosis if the damage is too severe. Rb blocks the G1/S transition until growth signals release it. Tumor suppressor mutations are loss-of-function, and because a cell usually has two copies, both alleles must generally be knocked out before the brake is truly gone — this is the two-hit idea, and it explains why inherited mutations in genes like BRCA1 raise risk without guaranteeing cancer: the person is born already one hit down in every cell.
| Feature | Proto-oncogene | Tumor suppressor gene |
|---|---|---|
| Normal role | Promotes division | Inhibits division, repairs DNA, triggers apoptosis |
| Cancer-causing mutation | Gain of function (too active) | Loss of function (inactivated) |
| Copies that must mutate | Usually one | Usually both |
| Analogy | Gas pedal stuck down | Brakes cut |
| Examples | Ras, HER2, myc | p53, Rb, BRCA1 |
How Accumulated Mutations Produce Cancer
Cancer requires multiple independent mutations in the same cell lineage — commonly cited estimates are four to seven driver mutations. One mutated gene is rarely enough, because the remaining controls still function. A cell with a stuck gas pedal but intact p53 will be detected and destroyed. Only when both a "go" signal is jammed on and several "stop" signals are disabled does the cell escape control entirely.
The process is a form of natural selection inside the body. A cell with one advantageous mutation divides slightly faster, producing a larger population of descendants. Because that population is larger and often has weakened DNA repair, the chance that one of them acquires a second driver mutation increases. Each new mutation is inherited by all subsequent descendants, so the abnormalities stack. This clonal, stepwise progression explains why cancer incidence rises sharply with age and why carcinogens — tobacco smoke, UV radiation, certain viruses — increase risk by raising the mutation rate rather than by causing cancer in a single step.
The resulting cell has a recognizable set of behaviors: it divides without growth factors, ignores density-dependent inhibition, evades apoptosis, and often reactivates telomerase so it does not age out. A mass of such cells is a tumor. A benign tumor stays localized; a malignant tumor invades surrounding tissue and can undergo metastasis, in which cells break away, travel through blood or lymph, and start secondary tumors elsewhere. Metastasis, not the original mass, causes most cancer deaths.
This is also why many treatments target the cell cycle. Radiation and many chemotherapy drugs damage DNA or disrupt spindle formation, hitting rapidly dividing cells hardest. The side effects — hair loss, nausea, low blood cell counts — occur because hair follicles, gut lining, and bone marrow are also rapidly dividing normal tissues.
The process is a form of natural selection inside the body. A cell with one advantageous mutation divides slightly faster, producing a larger population of descendants. Because that population is larger and often has weakened DNA repair, the chance that one of them acquires a second driver mutation increases. Each new mutation is inherited by all subsequent descendants, so the abnormalities stack. This clonal, stepwise progression explains why cancer incidence rises sharply with age and why carcinogens — tobacco smoke, UV radiation, certain viruses — increase risk by raising the mutation rate rather than by causing cancer in a single step.
The resulting cell has a recognizable set of behaviors: it divides without growth factors, ignores density-dependent inhibition, evades apoptosis, and often reactivates telomerase so it does not age out. A mass of such cells is a tumor. A benign tumor stays localized; a malignant tumor invades surrounding tissue and can undergo metastasis, in which cells break away, travel through blood or lymph, and start secondary tumors elsewhere. Metastasis, not the original mass, causes most cancer deaths.
This is also why many treatments target the cell cycle. Radiation and many chemotherapy drugs damage DNA or disrupt spindle formation, hitting rapidly dividing cells hardest. The side effects — hair loss, nausea, low blood cell counts — occur because hair follicles, gut lining, and bone marrow are also rapidly dividing normal tissues.
Reading Experimental Evidence About Cell Cycle Control
Much of what we know came from straightforward experiments you can reason through. In cell fusion experiments, a cell in M phase fused with a cell in G1 caused the G1 nucleus to condense its chromosomes prematurely — evidence that a diffusible cytoplasmic signal (mitotic cyclin-Cdk), not something built into the nucleus, triggers mitosis.
When you are handed data in class, work through it in a fixed order. First, identify where in the cycle the cells are stuck or where they are failing to stop. Cells accumulating with unreplicated DNA are blocked before S; cells accumulating in metaphase with unattached chromosomes are held by the spindle assembly checkpoint. Second, ask whether the defect is too much "go" or too little "stop." Cells dividing in a dish with no growth factor added point to an oncogene, because the go signal is being generated internally. Cells that divide normally when healthy but keep dividing after UV damage point to a lost tumor suppressor, because the damage-detection brake failed.
Third, watch the culture behavior. Normal cells stop at one layer; transformed cells stack up and do not need to be anchored. That single observation distinguishes regulated from unregulated growth without any genetic testing.
Students most often stumble by reversing the mutation types — writing that p53 became "overactive" in cancer, or that a proto-oncogene was "deleted." Anchor it with the analogy: you cause a crash by jamming the gas or cutting the brakes, never by removing the gas pedal or by making the brakes too strong. A cell with overactive p53 would divide too little, not too much.
When you are handed data in class, work through it in a fixed order. First, identify where in the cycle the cells are stuck or where they are failing to stop. Cells accumulating with unreplicated DNA are blocked before S; cells accumulating in metaphase with unattached chromosomes are held by the spindle assembly checkpoint. Second, ask whether the defect is too much "go" or too little "stop." Cells dividing in a dish with no growth factor added point to an oncogene, because the go signal is being generated internally. Cells that divide normally when healthy but keep dividing after UV damage point to a lost tumor suppressor, because the damage-detection brake failed.
Third, watch the culture behavior. Normal cells stop at one layer; transformed cells stack up and do not need to be anchored. That single observation distinguishes regulated from unregulated growth without any genetic testing.
Students most often stumble by reversing the mutation types — writing that p53 became "overactive" in cancer, or that a proto-oncogene was "deleted." Anchor it with the analogy: you cause a crash by jamming the gas or cutting the brakes, never by removing the gas pedal or by making the brakes too strong. A cell with overactive p53 would divide too little, not too much.
Key terms
- Checkpoint.
- A control point in the cell cycle where the cell verifies that conditions (size, nutrients, DNA integrity, spindle attachment) are acceptable before proceeding; if not, the cycle halts.
- Cyclin.
- A regulatory protein whose concentration rises and falls cyclically; it binds and activates a Cdk, setting the timing of cell cycle transitions.
- Cyclin-dependent kinase (Cdk).
- An enzyme present at constant levels that becomes active only when bound to a cyclin, then phosphorylates target proteins to drive the cell into the next phase.
- Proto-oncogene.
- A normal gene coding for a protein that promotes cell division; a gain-of-function mutation converts it into an oncogene that signals division continuously.
- Tumor suppressor gene.
- A gene coding for a protein that inhibits division, repairs DNA, or triggers apoptosis; cancer results from loss-of-function mutations, usually in both copies.
- p53.
- A tumor suppressor protein that responds to DNA damage by halting the cycle at G1 for repair or, if damage is severe, initiating apoptosis.
- Apoptosis.
- Programmed cell death, a controlled self-destruction pathway used to eliminate damaged or unneeded cells.
- Metastasis.
- The spread of malignant cells from the original tumor through blood or lymph to form secondary tumors in other tissues.
Worked example
A researcher grows three cell lines in dishes containing no added growth factor and then exposes each to a dose of UV light that causes DNA breaks. Results: Line A stops dividing immediately in the growth-factor-free medium. Line B divides steadily in the growth-factor-free medium and continues dividing after UV exposure. Line C stops dividing in the growth-factor-free medium, but when growth factor is added and UV is applied, it continues dividing with damaged DNA. Identify the likely regulatory defect in Lines B and C, and state which checkpoint fails in each.
Start with Line A as the control. It stops without growth factor, meaning its G1 checkpoint correctly detects the absence of an external "divide" signal. Line A is normal.
Now Line C. It behaves normally when growth factor is absent, so its growth factor receptor pathway and G1 signal detection are intact — the gas pedal is not stuck. Its failure appears only after DNA damage: it keeps cycling with broken DNA. Damage detection and the resulting halt are the job of tumor suppressor proteins such as p53 acting at the G1 checkpoint (with G2 also monitoring unrepaired breaks). So Line C most likely has a loss-of-function mutation in a tumor suppressor gene, and the damage-response arm of the G1 checkpoint fails.
Now Line B. It divides with no growth factor at all, which means the "divide" signal is being produced from inside the cell rather than received from outside. That is the signature of a gain-of-function mutation in a proto-oncogene, converting it to an oncogene — for example, a Ras protein locked in its active state, or a receptor that fires without a ligand. The G1 checkpoint is bypassed. Line B also ignores UV damage, which tells you it carries at least a second defect in damage response, since an intact p53 pathway would still arrest or kill a cell with broken DNA.
Conclusion: Line B carries an oncogene plus a compromised damage checkpoint; Line C carries an inactivated tumor suppressor. Line B illustrates the multiple-mutation model — it needed both a jammed accelerator and cut brakes to grow this freely.
Now Line C. It behaves normally when growth factor is absent, so its growth factor receptor pathway and G1 signal detection are intact — the gas pedal is not stuck. Its failure appears only after DNA damage: it keeps cycling with broken DNA. Damage detection and the resulting halt are the job of tumor suppressor proteins such as p53 acting at the G1 checkpoint (with G2 also monitoring unrepaired breaks). So Line C most likely has a loss-of-function mutation in a tumor suppressor gene, and the damage-response arm of the G1 checkpoint fails.
Now Line B. It divides with no growth factor at all, which means the "divide" signal is being produced from inside the cell rather than received from outside. That is the signature of a gain-of-function mutation in a proto-oncogene, converting it to an oncogene — for example, a Ras protein locked in its active state, or a receptor that fires without a ligand. The G1 checkpoint is bypassed. Line B also ignores UV damage, which tells you it carries at least a second defect in damage response, since an intact p53 pathway would still arrest or kill a cell with broken DNA.
Conclusion: Line B carries an oncogene plus a compromised damage checkpoint; Line C carries an inactivated tumor suppressor. Line B illustrates the multiple-mutation model — it needed both a jammed accelerator and cut brakes to grow this freely.
Practice questions
A mutation causes a cell's Rb protein to be completely nonfunctional. Rb normally blocks the G1-to-S transition until growth signals are received. What is the most likely immediate effect on the cell?
- The cell arrests permanently in G0 because it cannot detect growth factors
- The cell enters S phase and replicates its DNA even without adequate growth signals
- Mitotic cyclin fails to accumulate, so the cell cannot enter mitosis
- Sister chromatids fail to separate during anaphase
Answer: The cell enters S phase and replicates its DNA even without adequate growth signals
Rb is a tumor suppressor that acts as a brake at the G1/S transition. Removing a brake does not cause arrest — it removes a restraint, so the cell proceeds into S phase inappropriately. The G0 option reverses the logic (that would happen if Rb were overactive). Mitotic cyclin and anaphase involve the G2 and M checkpoints, which Rb does not control, so those options describe the wrong part of the cycle.
Explain why a single mutation in a proto-oncogene is usually not sufficient to cause cancer, and describe how additional mutations change the outcome. Reference at least one specific tumor suppressor in your answer.
Answer: One oncogene mutation produces excess division signaling, but intact tumor suppressor pathways still detect the abnormality. p53, for example, senses DNA damage and abnormal proliferation signals and responds by arresting the cell at G1 or triggering apoptosis, so the mutant cell is repaired or destroyed. Cancer requires that these safeguards also fail. If both copies of p53 are inactivated by later mutations, the cell can no longer arrest or self-destruct; it survives and passes both defects to all its descendants. Because that faster-dividing population is large and has weakened DNA repair, further driver mutations accumulate, eventually removing density-dependent inhibition, anchorage dependence, and limits on replicative lifespan. The result is a tumor, and additional changes allow invasion and metastasis.
The reasoning to show is that regulation is redundant: promoting division and permitting survival are separate controls. A strong answer names the gain-of-function versus loss-of-function distinction, explains that both p53 alleles must be lost, and describes clonal accumulation — each mutation is inherited by all descendants, so defects stack over years rather than appearing at once. Answers that stop at "the cell divides uncontrollably" miss the checkpoint that would have caught it.
In a culture dish, normal fibroblasts grow until they form a single layer covering the surface and then stop dividing. Cancer cells in an identical dish continue dividing and pile up in multiple layers. Name the two regulatory properties the cancer cells have lost and explain what each normally does.
Answer: They have lost density-dependent inhibition and anchorage dependence. Density-dependent inhibition normally stops division when a cell is surrounded by neighbors, which is why normal cells halt at a single confluent layer. Anchorage dependence normally requires a cell to be attached to a solid surface or extracellular matrix in order to divide, which prevents cells from proliferating while unattached. Losing both allows cancer cells to keep dividing in crowded conditions and to survive and grow while detached, a property that contributes to their ability to metastasize.
This is a classic observation because it distinguishes regulated from unregulated growth with no genetic data at all. The multiple layers show crowding no longer triggers arrest; growth while unattached shows the anchorage requirement is gone. Connect this back to the G1 checkpoint: both properties are external conditions the G1 checkpoint normally evaluates before the cell commits to S phase.
FAQ
- What is the difference between an oncogene and a proto-oncogene?
- A proto-oncogene is a normal, healthy gene that every cell carries; it codes for a protein that promotes cell division, which is essential for growth and wound healing. An oncogene is what a proto-oncogene becomes after a gain-of-function mutation makes it overactive or overexpressed. The gene is the same locus — the mutation is what changes its behavior. Oncogenes are not foreign genes or viral invaders in the typical case.
- Why do tumor suppressor genes usually need both copies mutated, while one oncogene mutation is enough?
- Think about what each mutation does. An oncogene actively produces a "divide" signal, and one loud signal is enough to be heard even if the other copy is normal — so it acts dominantly at the cellular level. A tumor suppressor works by being present and functional; if one copy is knocked out, the second still produces working protein and the brake still holds. Only when both alleles are lost does the function disappear. This is why inherited BRCA1 or Rb mutations raise risk: every cell already carries one hit.
- Which checkpoint is the most important, and why?
- The G1 checkpoint, sometimes called the restriction point, is generally considered the most critical. It is the last moment at which the cell can back out and enter G0 instead of committing to a full division cycle, and it integrates the most information: cell size, nutrient availability, growth factor signals from other cells, and DNA integrity. Once a cell passes G1, it is largely committed. Most cancer-associated mutations, including those in p53 and Rb, affect this checkpoint.
- How does chemotherapy relate to cell cycle regulation?
- Many chemotherapy drugs and radiation treatments work by damaging DNA or by interfering with spindle microtubule assembly. Cells that are dividing frequently encounter these problems more often and are more likely to die, so rapidly dividing tumor cells are hit hardest. The side effects follow from the same mechanism: hair follicle cells, the lining of the digestive tract, and bone marrow stem cells also divide rapidly, so they are damaged too, causing hair loss, nausea, and reduced blood cell counts.
Learn this with a teacher, not a page
The Crimsora tutor teaches Cell Cycle Regulation, Checkpoints & Cancer live — explaining on a whiteboard, asking you questions, and adapting to where you get stuck.